OCREVUS® (ocrelizumab) dosing and administration

Twice-yearly dosing schedule 3*

Learn more about the dosing schedule needed for your patients to start on OCREVUS (ocrelizumab).

Managing infusion-related reactions

Infusion-related reactions

See OCREVUS infusion-related reaction data and the recommendations for managing infusion-related reactions.

The Infusion Center Locator is non-medication and non-disease specific, so it contains sites that may not infuse OCREVUS or that may not be covered by a particular patients insurance provider.
DMT=disease-modifying therapy; PPMS=primary progressive multiple sclerosis; RMS=relapsing multiple sclerosis.